Atherosclerosis Supplements, 1567-5688

Journal

More filtering options
  1. 2010
  2. ACTIVE PHOSPHOLIPID TRANSFER PROTEIN (PLTP) REDUCES PROTHROMBIN ACTIVATION AND ATTENUATES BLOOD COAGULATION

    Oslakovic, C., Jauhiainen, M., Ehnholm, C. & Björn Dahlbäck, 2010, In : Atherosclerosis Supplements. 11, 2, p. P233

    Research output: Contribution to journalPublished meeting abstract

  3. ASSOCIATION OF VARIOUS POLYMORPHISMS WITH CAD IN NORTH INDIAN POPULATION: REPLICATION OF SNPS IDENTIFIED THROUGH GENOME WIDE ASSOCIATION STUDIES

    Kumar, J., Yumnam, S., Basu, T., Ghosh, A., Garg, G., Karthikeyan, G. & Sengupta, S., 2010, In : Atherosclerosis Supplements. 11, 2, p. P167

    Research output: Contribution to journalPublished meeting abstract

  4. BODY FAT RELATED TO RISK FACTORS FOR CVD IN YOUNGER CHILDREN

    Magnus Dencker, Ola Thorsson, Magnus Karlsson, Christian Lindén, Per Wollmer & Andersen, L. B., 2010, In : Atherosclerosis Supplements. 11, 2, p. MS191

    Research output: Contribution to journalPublished meeting abstract

  5. LDL INCREASES VASCULAR ETB2 RECEPTOR EXPRESSION VIA ACTIVATION OF ERK1/2 AND P38 MAPK PATHWAYS

    Zhang, Y., Zheng, J., Zhang, W., Lars Edvinsson & Xu, C-B., 2010, In : Atherosclerosis Supplements. 11, 2, p. P367

    Research output: Contribution to journalPublished meeting abstract

  6. THE ROLE OF SNARE PROTEINS IN HUMAN INSULIN RESISTANCE

    Bostrom, P., Andersson, L., Vind, B., Haversen, L., Wickstrom, Y., Larsson, E., Jansson, P. -A., Svensson, M., Branemark, R., Charlotte Ling, Beck-Nielsen, H., Boren, J., Hojlund, K. & Olofsson, S. -O., 2010, In : Atherosclerosis Supplements. 11, 2, p. P283

    Research output: Contribution to journalPublished meeting abstract

  7. 2009
  8. A Novel Mutation In CETP Gene As A Cause Of CETP Deficiency In A Caucasian Kindred

    Tarugi, P., Gomaraschi, M., Peter Nilsson, Favari, E., Adorni, M. P., Bernini, F., Sirtori, C., Franceschini, G. & Calabresi, L., 2009, In : Atherosclerosis Supplements. 10, 2

    Research output: Contribution to journalPublished meeting abstract

  9. Anticoagulant Properties Of Apolipoprotein A-I And Phospholipid Transfer Protein

    Oslakovic, C., Krisinger, M., Jauhiainen, M., Ehnholm, C. & Björn Dahlbäck, 2009, In : Atherosclerosis Supplements. 10, 2, p. e138-e138

    Research output: Contribution to journalPublished meeting abstract

  10. Apob-100 Peptide Immunization Reduce Macrophage Plaque Infiltration In Apobec1-/- Ldlr-/- Mice With Advanced Atherosclerotic Lesions

    Kolbus, D., Maria Wigren, Jan Nilsson & Nordin Fredrikson, G., 2009, In : Atherosclerosis Supplements. 10, 2

    Research output: Contribution to journalPublished meeting abstract

  11. Associations Between Human Leukocyte Antigen (HLA) Genotype And Acute Myocardial Infarction

    Harry Björkbacka, Lavant, E., Nordin Fredrikson, G., Olle Melander, Berglund, G., Jonas Carlson & Jan Nilsson, 2009, In : Atherosclerosis Supplements. 10, 2, p. e953-e953

    Research output: Contribution to journalPublished meeting abstract

  12. Diet-Induced Hyperlipidemia Activates Myd88-Dependent Innate Immune Signaling Resulting In Increased Leukocyte Rolling In Vivo

    Pistea, A., Berg, K., Lindholm, M., Zetterqvist, A., Öhman, J., Maria Gomez, Jan Nilsson, Henrik Thorlacius & Harry Björkbacka, 2009, In : Atherosclerosis Supplements. 10, 2

    Research output: Contribution to journalPublished meeting abstract

  13. Evidence Of A Role Of T Regulatory Cells Mediating Atheroprotection By APO B 100 Peptide Immunization

    Maria Wigren, Kolbus, D., Pontus Dunér, Harry Björkbacka, Nordin Fredrikson, G. & Jan Nilsson, 2009, In : Atherosclerosis Supplements. 10, 2, p. e885-e885

    Research output: Contribution to journalPublished meeting abstract

  14. Expression Of Apolipoprotein M In Fetal Liver: Impact Of Maternal Diabetes

    Christoffersen, C., Lindegaard, M., Axler, O., Damm, P., Björn Dahlbäck & Nielsen, L., 2009, In : Atherosclerosis Supplements. 10, 2, p. e714-e714

    Research output: Contribution to journalPublished meeting abstract

  15. FCGAMMARIIB Inhibits The Development Of Atherosclerosis In Mice

    Zhao, M., Harry Björkbacka, Jan Nilsson & Nordin Fredrikson, G., 2009, In : Atherosclerosis Supplements. 10, 2

    Research output: Contribution to journalPublished meeting abstract

  16. HDL From Carriers Of The R37X Mutation In CETP Gene And Endothelial Cell Homeostasis

    Calabresi, L., Pozzi, S., Peter Nilsson, Sirtori, C., Franceschini, G. & Gomaraschi, M., 2009, In : Atherosclerosis Supplements. 10, 2

    Research output: Contribution to journalPublished meeting abstract

  17. ION Mobility Analysis Of Lipoprotein Subfractions Suggests Three Independent Mechanisms Of Cardiovascular Risk

    Musunuru, K., Marju Orho-Melander, Caulfield, M., Reitz, R., Berglund, G., Bo Hedblad, Gunnar Engström, Kathiresan, S., Olle Melander & Krauss, R., 2009, In : Atherosclerosis Supplements. 10, 2, p. e17-e17

    Research output: Contribution to journalPublished meeting abstract

  18. Low Serum Levels Of DHEA Predict Death From Cardiovascular Disease In Older Men

    Ohlsson, C., Labrie, F., Barrett-Connor, E., Vandenput, L. & Karlsson, M., 2009, In : Atherosclerosis Supplements. 10, 2, p. e268-e268

    Research output: Contribution to journalPublished meeting abstract

  19. Osteopontin Is Pivotal For Development Of Uremic Atherosclerosis

    Pedersen, T., Bro, S., Anna Hultgårdh & Nielsen, L., 2009, In : Atherosclerosis Supplements. 10, 2, p. e1508-e1508

    Research output: Contribution to journalPublished meeting abstract

  20. Recombinant Apolipoprotein M Secretion Stimulated By HDL

    Ahnström, J., Axler, O. & Björn Dahlbäck, 2009, In : Atherosclerosis Supplements. 10, 2, p. e1175-e1175

    Research output: Contribution to journalPublished meeting abstract

  21. Relationship Between Plasma Apolipoprotein-M And High Density Lipoprotein Apoa Kinetics In Men

    Ooi, E., Watts, G., Chan, D., Nielsen, L. B., Plomgaard, P., Björn Dahlbäck & Barrett, H., 2009, In : Atherosclerosis Supplements. 10, 2, p. e729-e729

    Research output: Contribution to journalPublished meeting abstract

  22. Structural And Functional Features Of HDL From Carriers Of The R37X Mutation In CETP Gene

    Calabresi, L., Favari, E., Bernini, F., Peter Nilsson, Sirtori, C., Tarugi, P., Franceschini, G. & Gomaraschi, M., 2009, In : Atherosclerosis Supplements. 10, 2, p. e236-e236

    Research output: Contribution to journalPublished meeting abstract

  23. 2006
  24. Atherogenic effects of upper respiratory infections and passive smoking in children with type 1 diabetes mellitus

    Michal Odermarsky, Stefan Willers & Petru Liuba, 2006 Jun, In : Atherosclerosis Supplements. 7, 3, p. 351 1 p., We-P11:24.

    Research output: Contribution to journalPublished meeting abstract

  25. 2005
  26. Association between IGM against an aldehyde-modified peptide sequence in apo B-100 and progression of carotid disease

    Fredrikson, GN., Bo Hedblad, Berglund, G., Alm, R., Nilsson, JA., Alexandru Schiopu, Shah, PK. & Nilsson, J., 2005, In : Atherosclerosis Supplements. 6, 1, p. 65-65

    Research output: Contribution to journalPublished meeting abstract

  27. 2004
  28. Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis

    Alexandru Schiopu, Bengtsson, J., Söderberg, I., Sabina Janciauskiene, Lindgren, S., Ares, M., Shah, P. K., Carlsson, R., Jan Nilsson & Nordin Fredrikson, G., 2004, In : Atherosclerosis Supplements. 5, 1, p. 42

    Research output: Contribution to journalPublished meeting abstract